Future patient care at risk unless health research protected and boosted

January 08, 2020

Health research faces a crisis that could impact on patient care, says a new report led by 10 prominent figures in the NHS and academia.

The Academy of Medical Sciences' report raises the alarm about the number of research active NHS staff who are finding it increasingly difficult to find time for research. Support for research is not helped by the widening gap between universities and the NHS.

Released today (Wednesday 8 January) the report is calling for leaders in universities, the NHS and government to make urgent changes to protect and enhance research in the NHS. It sets out a powerful vision to enhance the NHS research culture and support provided by universities to make sure scientific discoveries boost the NHS and improve patient care.

The report calls for immediate action by giving NHS staff protected time to do research. This should begin by running an estimated £25 million pilot scheme to allow 1 in 5 consultants to have one day a week of their time protected for research in ten hospitals across the UK. It is expected that the scheme would become cost neutral or even save money in the longer term by improving recruitment and retention of NHS staff, reducing spending on agency staff, and increasing research funding from life sciences companies.

Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences, said:

"Protecting and strengthening research is a win-win situation for patients, the NHS, Universities and our economy. Research is the tonic the NHS needs right now.

"There is increasing evidence that shows that patients treated in research active hospitals get better quality of care, even if they are not taking part in a research project.

"Evidence also suggests that including research in medical roles makes it easier to attract and keep the best doctors. Research can also provide a coping mechanism to avoid burnout in NHS staff, so could make a dent in the £480 million yearly NHS spend on agency staff*."

The report also calls for:The NHS is uniquely placed to be the engine of health research. The historic research discoveries made in the NHS over the last 70 years show how much is at stake for patients. Discoveries include the development of penicillin as a drug, the invention of Magnetic Resonance Imaging (MRI) scanners, the development of in vitro fertilisation (IVF), DNA sequencing and making advances in immunology to allow organ transplantation.

Rob Lester, a retired GP from Fife in Scotland, was diagnosed with advanced prostate cancer aged 55. He has been treated with abiraterone - a drug discovered by The Institute of Cancer Research, London, and first shown to be effective for advanced prostate cancer by research developed through a partnership between The Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust.

Rob said of his treatment:

"I would call myself a lucky man - abiraterone has treated my cancer. Not only have I survived, but I am living my life and feeling better than I have in years. When I was first diagnosed with advanced prostate cancer, I hoped to survive 5 years - now I have already survived 7 years. I am alive simply because of research carried out in the NHS. We must do all we can to make sure that this type of research continues to happen in future."

Professor Sir Robert Lechler PMedSci, continued:

"We are enjoying an exciting era of unprecedented medical discovery. Patients need us to convert this progress into new cures and better care.

"You could ask whether, at a time of too few doctors and nurses and overstretched budgets, we can afford to give time and money to research. The Prime Minister has been absolutely clear that his Government will boost funding on the NHS. Whatever improvements are made to our health service, research is a critical priority. It is important to note that every pound spent on biomedical research returns about 25p every year, forever. So we can't afford not to do this both financially and more importantly for the health of us all.

"There is a lot at stake for the NHS and everyone treated by it. If we unite and act decisively we can boost the NHS and make sure that the breath taking scientific discoveries being made in the UK are converted into better patient care."

Despite the known benefits of research, the report highlights that many NHS Trusts see research as 'nice to have'. The number of medical clinical academics - NHS consultants employed by Universities to lead research - has decreased from 7.5% to 4.2% of NHS medical consultants from 2004 to 2017. Only 0.4% of GPs and 0.1% of nursing, midwifery and other health professionals had research as part of their role in 2017.
For more information, copies of the report, additional quotes, and requests for interview please contact: Naomi Clarke, Senior Communications Officer, Academy of Medical Sciences, 020 3141 3208, 07903 158979 or 07969 082520, naomi.clarke@acmedsci.ac.uk

The report 'Transforming health through innovation: integrating the NHS and academia' is available to download here

* NHS could free up £480m by limiting use of temporary staffing agencies, NHS England

**For more information about The Institute for Cancer Research, London, visit http://www.icr.ac.uk

Notes for Editors

1. The Academy of Medical Sciences is the independent body in the UK representing the diversity of medical science. Our elected Fellows are the UK's leading medical scientists from hospitals, academia, industry and the public service. Our mission is to advance biomedical and health research and its translation into benefits for society. We are working to secure a future in which: Our work focusses on four key objectives, promoting excellence, developing talented researchers, influencing research and policy and engaging patients, the public and professionals.


Academy of Medical Sciences (UK)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.